In 1987, Mayeux et al. reported the first case of myoclonus secondary to an acetylcholinesterase inhibitor.9 They described two patients with Alzheimer’s disease for whom physostigmine was prescribed. This evidence concerns the gene ACHE and early-onset autosomal dominant Alzheimer disease.